Prudential Financial’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5K Buy
2,844
+2,145
+307% +$47.9K ﹤0.01% 2451
2026
Q1
$18.4K Buy
699
+229
+49% +$28.8K ﹤0.01% 2379
2025
Q4
$117K Sell
470
-164
-26% -$37.4K ﹤0.01% 2112
2025
Q3
$133K Buy
634
+4
+0.6% +$705 ﹤0.01% 2257
2025
Q2
$62K Buy
630
+42
+7% +$3.67K ﹤0.01% 2325
2025
Q1
$51.8K Hold
588
– – ﹤0.01% 2197
2024
Q4
$42.6K Hold
588
– – ﹤0.01% 2225
2024
Q3
$46.4K Buy
+588
New +$45.3K ﹤0.01% 2654
2021
Q1
– Sell
-1,893
Closed -$1.46M – 2509
2020
Q4
$1.46M Buy
1,893
+834
+79% +$657K ﹤0.01% 1565
2020
Q3
$1.05M Buy
1,059
+3
+0.3% +$3.18K ﹤0.01% 1619
2020
Q2
$1.1M Buy
1,056
+514
+95% +$517K ﹤0.01% 1602
2020
Q1
$440K Buy
542
+4
+0.7% +$4.18K ﹤0.01% 1945
2019
Q4
$673K Buy
+538
New +$867K ﹤0.01% 1984

Other funds holding GOSS

Prudential Financial's GOSS Position: Q2 2026 in Review

Prudential Financial increased its Gossamer Bio (GOSS) stake by 307% in Q2 2026, buying an estimated $47.9K and bringing the position to 2,844 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Prudential Financial first reported a position in GOSS in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.46M in Q4 2020. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Prudential Financial held 2,844 shares of Gossamer Bio worth $37.5K as of Q2 2026.
  • Prudential Financial bought 2,145 Gossamer Bio shares in Q2 2026, an estimated $47.9K.
  • Gossamer Bio made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2451 holding.
  • Prudential Financial first reported a position in Gossamer Bio in Q4 2019 and has held it in 13 quarters since.
  • Prudential Financial's Gossamer Bio position peaked at $1.46M in Q4 2020.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.